The Reckoning of Restrictions and Research

Erica P. Johnson New US visa restrictions, prompted by fears of renewed terrorist attacks, present a dilemma to people in science: How does the government guarantee the public safety and yet sustain the free exchange of research and researchers? Many observers say post-Sept. 11 limitations have already put scientific research at risk. Visas are harder to get and sometimes denied. Federal grants arrive with strings attached--restricted participation by researchers from overseas. And some academ

Written byDana Wilkie
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

New US visa restrictions, prompted by fears of renewed terrorist attacks, present a dilemma to people in science: How does the government guarantee the public safety and yet sustain the free exchange of research and researchers? Many observers say post-Sept. 11 limitations have already put scientific research at risk. Visas are harder to get and sometimes denied. Federal grants arrive with strings attached--restricted participation by researchers from overseas. And some academics fear more of them will pursue careers elsewhere, draining the country of some of its brightest minds and compromising the role of the United States as a leader in scientific ideas and discovery.

"A lot of these students make tremendous impacts on the United States," says Steven Hoch, dean of International Programs at the University of Iowa, where federal authorities last fall refused at least 51 student visas. "They give a tremendous boost to our economy and to our ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies